Copyright Reports & Markets. All rights reserved.

Global Clinical Next-Generation Sequencing Sales Market(Sales,Revenue and competitors Analysis of Major Market)from 2014-2026

Request for Sample of this report
Buy now

Table of Contents

    1 Executive Summary

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Clinical Next-Generation Sequencing Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Targeted Sequencing
      • 2.1.2 Exome Sequencing
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Targeted Sequencing
      • 2.2.2 Exome Sequencing

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospitals and Clinics
      • 3.1.2 Biopharma Companies
      • 3.1.3 Academic and Research Organizations
      • 3.1.4 Others

    4 Manufacturers Profiles/Analysis

    • 4.1 Thermo Fisher Scientific
      • 4.1.1 Thermo Fisher Scientific Profiles
      • 4.1.2 Thermo Fisher Scientific Product Information
      • 4.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Sales, Sales Value(Million USD), Price and Gross Profit
      • 4.1.4 Thermo Fisher Scientific SWOT Analysis
    • 4.2 PerkinElmer
      • 4.2.1 PerkinElmer Profiles
      • 4.2.2 PerkinElmer Product Information
      • 4.2.3 PerkinElmer Clinical Next-Generation SequencingSales, Sales Value (Million USD), Price and Gross Profit
      • 4.2.4 PerkinElmer SWOT Analysis
    • 4.3 Illumina
      • 4.3.1 Illumina Profiles
      • 4.3.2 Illumina Product Information
      • 4.3.3 Illumina Clinical Next-Generation SequencingSales, Sales Value (Million USD), Price and Gross Profit
      • 4.3.4 Illumina SWOT Analysis
    • 4.4 Beckman Coulter
      • 4.4.1 Beckman Coulter Profiles
      • 4.4.2 Beckman Coulter Product Information
      • 4.4.3 Beckman Coulter Clinical Next-Generation SequencingSales, Sales Value (Million USD), Price and Gross Profit
      • 4.4.4 Beckman Coulter SWOT Analysis
    • 4.5 GATC Biotech
      • 4.5.1 GATC Biotech Profiles
      • 4.5.2 GATC Biotech Product Information
      • 4.5.3 GATC Biotech Clinical Next-Generation SequencingSales, Sales Value (Million USD), Price and Gross Profit
      • 4.5.4 GATC Biotech SWOT Analysis
    • 4.6 Qiagen
      • 4.6.1 Qiagen Profiles
      • 4.6.2 Qiagen Product Information
      • 4.6.3 Qiagen Clinical Next-Generation SequencingSales, Sales Value (Million USD), Price and Gross Profit
      • 4.6.4 Qiagen SWOT Analysis
    • 4.7 Roche
      • 4.7.1 Roche Profiles
      • 4.7.2 Roche Product Information
      • 4.7.3 Roche Clinical Next-Generation SequencingSales, Sales Value (Million USD), Price and Gross Profit
      • 4.7.4 Roche SWOT Analysis
    • 4.8 Pacific Bioscience
      • 4.8.1 Pacific Bioscience Profiles
      • 4.8.2 Pacific Bioscience Product Information
      • 4.8.3 Pacific Bioscience Clinical Next-Generation SequencingSales, Sales Value (Million USD), Price and Gross Profit
      • 4.8.4 Pacific Bioscience SWOT Analysis
    • 4.9 Agilent Technologies
      • 4.9.1 Agilent Technologies Profiles
      • 4.9.2 Agilent Technologies Product Information
      • 4.9.3 Agilent Technologies Clinical Next-Generation SequencingSales, Sales Value (Million USD), Price and Gross Profit
      • 4.9.4 Agilent Technologies SWOT Analysis
    • 4.10 Macrogen
      • 4.10.1 Macrogen Profiles
      • 4.10.2 Macrogen Product Information
      • 4.10.3 Macrogen Clinical Next-Generation SequencingSales, Sales Value (Million USD), Price and Gross Profit
      • 4.10.4 Macrogen SWOT Analysis
    • 4.11 Oxford Nanopore
    • 4.12 Foundation Medicine
    • 4.13 Life technologies
    • 4.14 Exosome Diagnostics
    • 4.15 CLC Bio
    • 4.16 Paradigm
    • 4.17 Partek
    • 4.18 GnuBIO
    • 4.19 Caris Life Sciences
    • 4.20 Others

    5 Market Performance for Manufacturers

    • 5.1 Global Clinical Next-Generation Sequencing Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Global Clinical Next-Generation Sequencing Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Global Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Global Clinical Next-Generation Sequencing Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 China Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 China Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 China Clinical Next-Generation Sequencing Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 USA Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 USA Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 USA Clinical Next-Generation Sequencing Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 Europe Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 Europe Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 Europe Clinical Next-Generation Sequencing Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Japan Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Japan Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Japan Clinical Next-Generation Sequencing Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Korea Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Korea Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Korea Clinical Next-Generation Sequencing Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 India Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 India Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 India Clinical Next-Generation Sequencing Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Southeast Asia Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Southeast Asia Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Southeast Asia Clinical Next-Generation Sequencing Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 South America Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 South America Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 South America Clinical Next-Generation Sequencing Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Global Clinical Next-Generation Sequencing Market Assessment by Regions (2014-2020)

    • 7.1 Global Clinical Next-Generation Sequencing Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Global Clinical Next-Generation Sequencing Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Global Clinical Next-Generation Sequencing Price (USD/Unit) by Regions 2014-2020
    • 7.4 Global Clinical Next-Generation Sequencing Gross Margin by Regions 2014-2020

    8 Development Trend for Regions

    • 8.1 Global Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.2 China Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.3 USA Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 Europe Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.5 Japan Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.6 Korea Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.7 India Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate 2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Manufacturing Plants Distribution

    11 Consumer Analysis

    • 11.1 Hospitals and Clinics Industry
    • 11.2 Biopharma Companies Industry
    • 11.3 Academic and Research Organizations Industry
    • 11.4 Others Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Global Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Global Clinical Next-Generation Sequencing Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 China Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 USA Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 Europe Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Japan Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Korea Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 India Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Southeast Asia Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.10 South America Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Targeted Sequencing
      • 12.2.3 Exome Sequencing
    • 12.3 Sales (K Units) Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Hospitals and Clinics
      • 12.3.3 Biopharma Companies
      • 12.3.4 Academic and Research Organizations
      • 12.3.5 Others
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Clinical Next-Generation Sequencing Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Global Clinical Next-Generation Sequencing Gross Profit Trend 2021-2026

    13 Conclusion

    In this report, our team research the global Clinical Next-Generation Sequencing market by type, application, region and manufacturer 2014-2020 and forcast 2021-2026. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.

    Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Clinical Next-Generation Sequencing for these regions, from 2014 to 2026 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    Global Clinical Next-Generation Sequencing market competition by top manufacturers/players, with Clinical Next-Generation Sequencing sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    Thermo Fisher Scientific
    PerkinElmer
    Illumina
    Beckman Coulter
    GATC Biotech
    Qiagen
    Roche
    Pacific Bioscience
    Agilent Technologies
    Macrogen
    Oxford Nanopore
    Foundation Medicine
    Life technologies
    Exosome Diagnostics
    CLC Bio
    Paradigm
    Partek
    GnuBIO
    Caris Life Sciences
    Others
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Targeted Sequencing
    Exome Sequencing
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Clinical Next-Generation Sequencing for each application, including
    Hospitals and Clinics
    Biopharma Companies
    Academic and Research Organizations
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.
    Buy now